What is the current market size and future outlook for the hydrophilic angiographic catheters market?
The hydrophilic angiographic catheters market size has grown strongly in recent years. It will grow from $12.6 $ billion in 2024 to $13.54 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the growing prevalence of cardiovascular diseases, rising incidence of peripheral vascular diseases, increase in diagnostic and interventional procedures, increasing awareness and early diagnosis, and rising healthcare expenditure.
The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $17.88 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to a growing aging population, a growing preference for minimally invasive procedures, a rising prevalence of diabetes, and increased funding for cardiovascular research. Major trends in the forecast period include technological advancements, expansion into emerging markets, advances in imaging technology, growing use in oncology, and focus on minimally invasive procedures.
Get Your Free Sample of The Global Hydrophilic Angiographic Catheters Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19515&type=smp
How has the hydrophilic angiographic catheters market evolved, and what factors have shaped its growth?
The growth in the prevalence of renal disorders is expected to propel the growth of the hydrophilic angiographic catheters market going forward. Renal disorders refer to a broad category of conditions that affect the kidneys, impairing their ability to filter blood, remove waste, balance fluids and electrolytes, and regulate blood pressure. Renal disorders are growing primarily due to the increasing prevalence of risk factors such as diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are used in renal disorders for precise and smooth navigation during diagnostic and interventional procedures, such as renal artery angiography and stenting. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the growth in the prevalence of renal disorders is driving the hydrophilic angiographic catheters market.
What are the major segments of the hydrophilic angiographic catheters market?
The hydrophilic angiographic cathetersmarket covered in this report is segmented –
1) By Type: Selective Type Angiographic Catheters, Non-Selective Type Angiographic Catheters
2) By Application: Heart Disease Treatment, Kidney Disease Treatment, Other Applications
3) By End User: Hospitals, Diagnostic And Imaging Centers, Other End-Users
Subsegments:
1) By Selective Type Angiographic Catheters: Coronary Selective Catheters, Peripheral Selective Catheters, Neuro Selective Catheters
2) By Non-Selective Type Angiographic Catheters: Non-Selective Coronary Catheters, Non-Selective Peripheral Catheters, Non-Selective Neuro Catheters
Order your report now for swift delivery
Which companies dominate the hydrophilic angiographic catheters market?
Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc., Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, Invamed Group
How will evolving trends contribute to the growth of the hydrophilic angiographic catheters market?
Major companies in the hydrophilic angiographic catheters market focus on developing innovative products such as catheters with various curve configurations to sustain their position in the market. Catheters with various curve configurations are specialized medical devices designed with different bending or curving shapes to navigate complex anatomical structures. For instance, in January 2024, Cook Group Incorporated, a US-based medical device company, launched its Slip-Cath Beacon Tip hydrophilic selective catheter in the USA and Canada. Designed for use in both vascular and non-vascular angiographic procedures, this catheter features over 30 different curve configurations and comes in protective foil packaging to ensure extended durability and a three-year shelf life. Its advanced technology enhances usability during procedures, and it is intended to work seamlessly with vascular access sheaths, wire guides, and various treatment devices.
What are the key regional dynamics of the hydrophilic angiographic catheters market, and which region leads in market share?
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2024. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Hydrophilic Angiographic Catheters Market Report 2025 Offer?
The hydrophilic angiographic catheters market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Hydrophilic angiographic catheters are specialized medical devices used in interventional radiology and cardiology. They feature a hydrophilic coating that significantly reduces friction, enabling smoother navigation through complex vascular pathways. These catheters facilitate easier handling and control during diagnostic and therapeutic procedures for cardiovascular diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19515
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
